APA (7th ed.) Citation

SR, M., JC, S., GA, R., D, C., Q, Z., N, R., . . . BS, P. (2014). Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: Implications for the 8-aminoquinoline class of anti-malarial compounds. Malaria journal, 13, 2. https://doi.org/10.1186/1475-2875-13-2

Chicago Style (17th ed.) Citation

SR, Marcsisin, et al. "Tafenoquine and NPC-1161B Require CYP 2D Metabolism for Anti-malarial Activity: Implications for the 8-aminoquinoline Class of Anti-malarial Compounds." Malaria Journal 13 (2014): 2. https://doi.org/10.1186/1475-2875-13-2.

MLA (9th ed.) Citation

SR, Marcsisin, et al. "Tafenoquine and NPC-1161B Require CYP 2D Metabolism for Anti-malarial Activity: Implications for the 8-aminoquinoline Class of Anti-malarial Compounds." Malaria Journal, vol. 13, 2014, p. 2, https://doi.org/10.1186/1475-2875-13-2.